Kelly C. Lee, Pharm.D., BCPP
Assistant Professor of Clinical Pharmacy
UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences
Dr. Kelly Lee is an Assistant Professor of Clinical Pharmacy. Dr. Lee received her Doctor of Pharmacy degree from the University of California, San Francisco. She completed a pharmacy practice residency and a two-year fellowship in Behavioral Health Sciences also at UCSF. At UCSD, Dr. Lee is responsible for coordinating and teaching in the Therapeutics course (SPPS 212C) that focuses on neurologic and psychiatric disorders. She also participates in the Pharmacy Practice course and is an attending pharmacist for the Free Clinics.
Dr. Lee is board certified in psychiatric pharmacy by the Board of Pharmaceutical Specialties. Dr. Lee's current research interests involve studying genetic differences in minority patients, specifically Asians, with psychiatric disorders. Dr. Lee is also investigating the extent of research training among junior faculty in schools of pharmacy across the Unites States and its correlation with academic productivity. Dr. Lee has authored several articles and book chapters in peer-reviewed journals and textbooks. She currently serves as a Section Co-Editor of Psychiatry in the textbook, Applied Therapeutics: The Clinical Use of Drugs. She is also involved in professional organizations such as the American College of Clinical Pharmacy (ACCP) and College of Psychiatric and Neurologic Pharmacists (CPNP).
Lee KC, Finley PR, Alldredge BK. Risk of seizures associated with psychotropic medications: Emphasis on new drugs and new findings. Expert Opinion on Drug Safety 2003;2(3):233-247.
El-Ibiary SY, Lee KC. Novel uses of SSRIs in women. J Pharmacy Practice 2003;16(3):191-199.
Lee KC. Detection and management of postpartum depression. The Female Patient 2004;29(11): 34-39.
Lee KC, Garcia PA, Alldredge BK. Treatment response and short-term outcome in patients with status epilepticus and HIV. Neurology 2005;65:314-316.
Lee KC, Ray GT, Hunkeler EM, Finley PR. Tamoxifen treatment and new-onset depression in breast cancer patients. Psychosomatics 2007, May-Jun; 48(3):205-10.
